Stocks Technology HCAT
NASDAQ · TechnologyHealth Catalyst, Inc. (HCAT)
Health Catalyst, Inc. brought in $272.2M of revenue over the twelve months to September 30, 2026, down 13.9% from a year earlier. It posted a net loss of $202.1M. In fiscal 2025 capital spending exceeded operating cash flow by $237K. At September 30, 2026 it held $53.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Health Catalyst, Inc.
- Net worth
- Health Catalyst, Inc. has a market value (market cap) of $109.9M at the latest share price, and shareholders' equity of $145.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $311.1M (+1.5% year on year), with a net loss of $178M. Over the 12 months to September 30, 2026: revenue $272.2M, net loss $202.1M.
- Cash flow
- In fiscal 2025 operations brought in $731K of cash; after $968K of capital spending, free cash flow was -$237K.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Health Catalyst, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Health Catalyst, Inc. does
Health Catalyst, Inc. is registered with the SEC under industry code SIC 7370 (Services-Computer Programming, Data Processing, Etc.). Its shares trade on NASDAQ under the ticker HCAT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $311.1M | -$178M | -$2.55 | -$237K |
| 2024 | $306.6M | -$69.5M | -$1.15 | $12.9M |
| 2023 | $295.9M | -$118.1M | -$2.09 | -$34.3M |
| 2022 | $276.2M | -$137.4M | -$2.63 | -$37.4M |
| 2021 | $241.9M | -$153.2M | -$3.23 | -$33.6M |
| 2020 | $188.8M | -$115M | -$2.91 | -$33.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where HCAT ranks in Technology
Latest SEC filings
What Health Catalyst, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 26% to $56.3M versus the same quarter last year; diluted EPS $0.53 versus -$0.32.
- November 5, 2026
- September 14, 2026
- September 14, 2026
- September 8, 2026Activist stake changed SCHEDULE 13D/A
- September 8, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 13% to $70.5M versus the same quarter last year; diluted EPS -$0.55 versus -$0.59.
- August 6, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Health Catalyst, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $105.4K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Reller TamiDirector | Received as pay | 128,851 | - |
| September 14, 2026 | Kohl SimeonChief Executive Officer, Director | Received as pay | 2,747,385 | - |
| September 14, 2026 | Kohl SimeonChief Executive Officer, Director | Bought | 59,000 | $105.4K |
| September 10, 2026 | Albert BenjaminCEO, Director | Shares withheld for tax | 35,244 | $59K |
| September 1, 2026 | Larson-Green JulieDirector | Received as pay | 9,766 | - |
| September 1, 2026 | Alger JasonChief Financial Officer | Shares withheld for tax | 17,973 | $30.6K |
| September 1, 2026 | Landry BenjaminGeneral Counsel | Shares withheld for tax | 13,167 | $22.4K |
| September 1, 2026 | Albert BenjaminCEO, Director | Shares withheld for tax | 321 | $546.9 |
Who owns HCAT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mathew P. Arens13D, may seek influence with 1 related filers | 18.3% | March 13, 2026 |
| Coghill Clint D13G, passive with 4 related filers | 9.6% | August 14, 2026 |
| Palogic Value Management, LP13D, may seek influence with 3 related filers | 7.1% | September 8, 2026 |
| Impax Asset Management Group plc13G, passive with 1 related filers | 5.4% | July 21, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 127 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| First Light Asset Management, LLC | 12,810,861 | -67,839 |
| CDC Financial, Inc. | 7,092,698 | +785,644 |
| Palogic Value Management, L.P. | 4,922,442 | +2,025,842 |
| Impax Asset Management Group plc | 4,000,000 | +1,250,000 |
| Nepsis Inc. | 2,976,187 | +1,099,898 |
| Vanguard Capital Management LLC | 2,971,598 | +85,945 |
| BlackRock, Inc. | 1,836,373 | -3,301,649 |
| Jane Street Group, LLC | 1,037,782 | +1,011,214 |
| Dimensional Fund Advisors LP | 911,819 | -323,051 |
| Geode Capital Management, LLC | 891,357 | -610,076 |
| HighMark Wealth Management LLC | 871,082 | -32,000 |
| Caption Management, LLC | 773,650 | +1,764 |
| Mink Brook Asset Management LLC | 738,277 | new |
| Prescott Group Capital Management, L.L.C. | 710,803 | 0 |
| Charles Schwab Investment Management Inc | 615,504 | +8,646 |
| Millennium Management LLC | 516,083 | new |
| Goldman Sachs Group Inc | 480,970 | +93,798 |
| Vanguard Fiduciary Trust Co | 463,005 | +19,340 |
| Citadel Advisors LLC | 453,214 | new |
| Susquehanna International Group, Llp | 437,227 | +356,073 |
Insiders
13 insiders reported holding 8,349,312 shares in total, about $12.2M at the last price.
| Holder | Shares |
|---|---|
| Kohl SimeonChief Executive Officer, Director | 2,856,385 |
| Burton Daniel D.Chief Executive Officer, Director | 1,393,099 |
| Albert BenjaminCEO, Director | 1,388,406 |
| Alger JasonChief Financial Officer | 704,867 |
| Freeman Kevin LeeChief Commercial Officer | 358,686 |
| Landry BenjaminGeneral Counsel | 351,372 |
| Llewelyn LindaChief People Officer | 321,132 |
| Nelson Steven HDirector | 235,499 |
| Larson-Green JulieDirector | 185,101 |
| Spencer JustinDirector | 149,263 |
Questions about HCAT
What does Health Catalyst, Inc. do?
Health Catalyst, Inc. is a company in the Technology sector, listed on NASDAQ as HCAT. Its shares trade on NASDAQ under the ticker HCAT.
What is Health Catalyst, Inc.'s net worth?
Health Catalyst, Inc. has a market value (market cap) of $109.9M at the latest share price, and shareholders' equity of $145.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Health Catalyst, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $202.1M on revenue of $272.2M.
How much revenue does Health Catalyst, Inc. make?
Over the twelve months to September 30, 2026 Health Catalyst, Inc. reported revenue of $272.2M. That is 13.9% less than a year earlier.
When did Health Catalyst, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Health Catalyst, Inc.'s next earnings report?
Health Catalyst, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare HCAT with
Follow HCAT
Get an email when Health Catalyst, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Health Catalyst, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.